Diagnostic testing is at the forefront of the COVID-19 pandemic, influencing public health decisions and shining a light on the value of In Vitro Diagnostics. In this Webinar, experts will provide an overview of the current global state of COVID-19 testing as well as share expectations on how the pandemic will impact the IVD industry overall, including how industry dynamics will be shaped throughout 2020.

Speakers

• Greg Stutman, Director, Laboratory and Point-of-Care Diagnostics, IQVIA IVD Solutions
• Sunayana Karra, Senior Consultant, Infectious Disease and Molecular Diagnostics, IQVIA IVD Solutions